Faheem W Guirgis, MD, FACEP
Associate Professor; Program Director, Emergency Medicine And Acute Care Research Fellowship
Department:
Emergency Medicine – Jacksonville
Business Phone:
(904) 244-4986
Business Email:
faheem.guirgis@jax.ufl.edu
About Faheem W Guirgis
Dr. Faheem W. Guirgis, MD, FACEP is an Associate Professor of Emergency Medicine in the Department of Emergency Medicine at the University of Florida College of Medicine in Jacksonville. He received his medical degree from The Chicago Medical School at Rosalind Franklin University and his Emergency Medicine residency training at the Albert Einstein College of Medicine in the Bronx, NY. Dr. Guirgis’ clinical and research work focuses on sepsis, and more specifically on mechanisms of lipid dysregulation, clinical implications, and novel therapies. Dr. Guirgis has been the PI of numerous clinical trials and translational research projects in sepsis and critical care, including the LIPid Intensive Drug therapy for Sepsis-Pilot (LIPIDS-P) of his own design. He has a diverse portfolio of active research funding from NIH and other sources. Dr. Guirgis has been recognized for his role in the design of a novel Sepsis Alert Program implemented at UF Health Jacksonville which has led to improved outcomes in patients admitted with sepsis.
Board Certifications
-
Emergency MedicineAmerican Board of Emergency Medicine
Clinical Profile
Specialties
- Emergency Medicine
Research Profile
Dr. Guirgis’ clinical and research work focuses on sepsis, and more specifically on mechanisms of lipid dysregulation, clinical implications, and novel therapies. Dr. Guirgis has been the PI of numerous clinical trials and translational research projects in sepsis and critical care, including the LIPid Intensive Drug therapy for Sepsis-Pilot (LIPIDS-P) of his own design. He has a diverse portfolio of active research funding from NIH and other sources. Dr. Guirgis has been recognized for his role in the design of a novel Sepsis Alert Program implemented at UF Health Jacksonville which has led to improved outcomes in patients admitted with sepsis.
Open Researcher and Contributor ID (ORCID)
0000-0002-4445-3939
Publications
2020
Development of a Simple Sequential Organ Failure Assessment Score for Risk Assessment of Emergency Department Patients With Sepsis.
Journal of intensive care medicine.
35(3):270-278
[DOI] 10.1177/0885066617741284.
[PMID] 29141524.
2020
Time to vasopressor initiation and organ failure progression in early septic shock.
Journal of the American College of Emergency Physicians open.
1(3):222-230
[DOI] 10.1002/emp2.12060.
[PMID] 33000037.
2020
Sequential Organ Failure Assessment Component Score Prediction of In-hospital Mortality From Sepsis.
Journal of intensive care medicine.
35(8):810-817
[DOI] 10.1177/0885066618795400.
[PMID] 30165769.
2020
Response to the Letter: “Bias estimation of predictors and internal validity of the study ‘Admission characteristics predictive of in-hospital death from hospital-acquired sepsis: A comparison to community-acquired sepsis'”.
Journal of critical care.
56
[DOI] 10.1016/j.jcrc.2019.04.023.
[PMID] 31060766.
2020
Lipid intensive drug therapy for sepsis pilot: A Bayesian phase I clinical trial.
Journal of the American College of Emergency Physicians open.
1(6):1332-1340
[DOI] 10.1002/emp2.12237.
[PMID] 33392541.
2020
Quantitative and Qualitative Assessments of Cholesterol Association With Bacterial Infection Type in Sepsis and Septic Shock.
Journal of intensive care medicine.
[DOI] 10.1177/0885066620931473.
[PMID] 32578468.
2020
Response to Editor letter “Admission characteristics predictive of in-hospital death from hospital-acquired sepsis: A comparison to community-acquired sepsis”.
Journal of critical care.
56:319-320
[DOI] 10.1016/j.jcrc.2019.04.024.
[PMID] 31056223.
2019
Admission characteristics predictive of in-hospital death from hospital-acquired sepsis: A comparison to community-acquired sepsis.
Journal of critical care.
51:145-148
[DOI] 10.1016/j.jcrc.2019.02.023.
[PMID] 30825788.
2019
Barriers to Utilizing Social Media Platforms in Emergency Medicine Residency Programs.
Cureus.
11(10)
[DOI] 10.7759/cureus.5856.
[PMID] 31763079.
2019
PCSK9 loss-of-function variants and risk of infection and sepsis in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort.
PloS one.
14(2)
[DOI] 10.1371/journal.pone.0210808.
[PMID] 30726226.
2019
LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock.
BMJ open.
9(9)
[DOI] 10.1136/bmjopen-2019-029348.
[PMID] 31537565.
2018
Effect of Levocarnitine vs Placebo as an Adjunctive Treatment for Septic Shock: The Rapid Administration of Carnitine in Sepsis (RACE) Randomized Clinical Trial.
JAMA network open.
1(8)
[DOI] 10.1001/jamanetworkopen.2018.6076.
[PMID] 30646314.
2018
HDL Cholesterol Efflux is Impaired in Older Patients with Early Sepsis: A Subanalysis of a Prospective Pilot Study.
Shock (Augusta, Ga.).
50(1):66-70
[DOI] 10.1097/SHK.0000000000001030.
[PMID] 29049133.
2018
HDL inflammatory index correlates with and predicts severity of organ failure in patients with sepsis and septic shock.
PloS one.
13(9)
[DOI] 10.1371/journal.pone.0203813.
[PMID] 30216360.
2018
Points & Pearls: Updates and controversies in the early management of sepsis and septic shock
Emergency medicine practice.
20(Suppl 10):1-2
[PMID] 30280868.
View on:
PubMed
2018
Updates and controversies in the early management of sepsis and septic shock.
Emergency medicine practice.
20(10):1-28
[PMID] 30252228.
View on:
PubMed
2017
Clinical predictors of early death from sepsis.
Journal of critical care.
42:30-34
[DOI] 10.1016/j.jcrc.2017.06.024.
[PMID] 28668774.
2017
Exploring the Predictive Ability of Dysfunctional High-Density Lipoprotein for Adverse Outcomes in Emergency Department Patients with Sepsis: A Preliminary Investigation.
Shock (Augusta, Ga.).
48(5):539-544
[DOI] 10.1097/SHK.0000000000000887.
[PMID] 28452909.
2017
Naloxone Triggering the RRT: A Human Antidote?
Journal of patient safety.
13(1):20-24
[DOI] 10.1097/PTS.0000000000000099.
[PMID] 24618648.
2017
The Impact of the Sepsis-3 Septic Shock Definition on Previously Defined Septic Shock Patients.
Critical care medicine.
45(9):1436-1442
[DOI] 10.1097/CCM.0000000000002512.
[PMID] 28542029.
2017
Managing sepsis: Electronic recognition, rapid response teams, and standardized care save lives.
Journal of critical care.
40:296-302
[DOI] 10.1016/j.jcrc.2017.04.005.
[PMID] 28412015.
2016
Cholesterol levels and long-term rates of community-acquired sepsis.
Critical care (London, England).
20(1)
[DOI] 10.1186/s13054-016-1579-8.
[PMID] 28010729.
2016
End-tidal carbon dioxide and occult injury in trauma patients: ETCO2 does not rule out severe injury.
The American journal of emergency medicine.
34(11):2146-2149
[DOI] 10.1016/j.ajem.2016.08.007.
[PMID] 27567419.
2016
The long-term burden of severe sepsis and septic shock: Sepsis recidivism and organ dysfunction.
The journal of trauma and acute care surgery.
81(3):525-32
[DOI] 10.1097/TA.0000000000001135.
[PMID] 27398984.
2016
Ultrasound-Guided Peripheral Intravenous Catheter Training Results in Physician-Level Success for Emergency Department Technicians.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
35(11):2343-2352
[PMID] 27629755.
View on:
PubMed
2015
The bubble study: ultrasound confirmation of central venous catheter placement.
The American journal of emergency medicine.
33(3):315-9
[DOI] 10.1016/j.ajem.2014.10.010.
[PMID] 25550065.
2015
The relationship of intravenous fluid chloride content to kidney function in patients with severe sepsis or septic shock.
The American journal of emergency medicine.
33(3):439-43
[DOI] 10.1016/j.ajem.2014.12.013.
[PMID] 25650359.
2014
Persistent organ dysfunction after severe sepsis: a systematic review.
Journal of critical care.
29(3):320-6
[DOI] 10.1016/j.jcrc.2013.10.020.
[PMID] 24360598.
2014
Long-Term Organ Dysfunction After Severe Sepsis
Critical Care Medicine.
42(12, S)
2014
Carotid intima media thickness and low high-density lipoprotein (HDL) in South Asian immigrants: could dysfunctional HDL be the missing link?
Archives of medical science : AMS.
10(5):870-9
[DOI] 10.5114/aoms.2014.46208.
[PMID] 25395937.
2014
End-tidal carbon dioxide as a goal of early sepsis therapy.
The American journal of emergency medicine.
32(11):1351-6
[DOI] 10.1016/j.ajem.2014.08.036.
[PMID] 25205615.
2014
Impact of an abbreviated cardiac enzyme protocol to aid rapid discharge of patients with cocaine-associated chest pain in the clinical decision unit.
The western journal of emergency medicine.
15(2):180-3
[DOI] 10.5811/westjem.2013.11.19232.
[PMID] 24672608.
2013
Proactive rounding by the rapid response team reduces inpatient cardiac arrests.
Resuscitation.
84(12):1668-73
[DOI] 10.1016/j.resuscitation.2013.08.013.
[PMID] 23994805.
2013
Rapid Discharge of Patients Presenting To the Emergency Department With Cocaine Chest Pain: Application of An Abbreviated Cardiac Enzyme Protocol in the Clinical Decision Unit
Annals of Emergency Medicine.
62
2013
Successful Implementation of Proactive Rounding By a Rapid Response Team in a Tertiary, Academic, Level 1 Trauma Center Reduces Inpatient Cardiac Arrests and Facilitates Preemptive Transfer To a Higher Level of Care
Annals of Emergency Medicine.
62
Grants
Jun 2020
ACTIVE
COVID:A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
Role: Principal Investigator
Funding: LEIDOS
via NATL INST OF HLTH NCI
Jun 2020
– Nov 2020
COVID-19: Multi-center registry of potential COVID-19 patients presenting to US Emergency Departments
Role: Principal Investigator
Funding: INDIANA UNIV
Apr 2020
ACTIVE
COVID-19: Angiotensin Receptor blockers for novel SAR-CoV-2
Role: Co-Investigator
Funding: UNIV OF MINNESOTA
via GATES FOU, BILL & MELINDA
Apr 2020
ACTIVE
The Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis
Role: Principal Investigator
Funding: NATL INST OF HLTH NIGMS
Sep 2018
ACTIVE
A 3D Tissue Map of the Human Lymphatic System
Role: Project Manager
Funding: NATL INST OF HLTH NIAID
Jun 2018
ACTIVE
OR-DRPD-ROF2018: The LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P) Trial
Role: Principal Investigator
Funding: UF RESEARCH
Jan 2018
– Dec 2019
Vitamin C, Thiamine and Steroids in Sepsis- multi-center, randomized, placebo-controlled, double-blind, adaptive clinical trial of vitamin C, thiamine and steroids as combination therapy in patients with sepsis.
Role: Principal Investigator
Funding: JOHNS HOPKINS UNIV
via MARCUS FOU
Apr 2017
ACTIVE
HSC COM Matching Commitment
Role: Project Manager
Funding: UNIV OF FLORIDA
Sep 2016
– Aug 2020
The Role of Dysfunctional HDL in Sepsis
Role: Principal Investigator
Funding: NATL INST OF HLTH NIGMS
Apr 2016
– Mar 2017
TOGETHER: TRANSFORMING AND TRANSLATING DISCOVERY TO IMPROVE ,HEALTH ,
Role: Project Manager
Funding: NATL INST OF HLTH NCATS
Jan 2015
– Jan 2018
The Role of Dysfunctional HDL in Sepsis
Role: Principal Investigator
Funding: SOCIETY OF CRITICAL CARE MEDICINE
Mar 2014
– May 2018
Rapid Administration of Carnitine in Sepsis (RACE)
Role: Principal Investigator
Funding: UNIV OF MISSISSIPPI
via NATL INST OF HLTH NIGMS
Education
Emergency Medicine Residency
2006-2010
·
Albert Einstein College of Medicine, Bronx, New York
Doctor of Medicine
2002-2006
·
Rosalind Franklin University, North Chicago, Illinois
Teaching Profile
Courses Taught
2018
MDC7710 Sr Emerg Med Clerkshp
Contact Details
Phones:
- Business:
- (904) 244-4986
Emails:
- Business:
- faheem.guirgis@jax.ufl.edu
Executive Assistant – EM Research:
